ElizabethMittendorfMD

General Surgery • Boston, MA

Breast, Surgical Oncology (Other than Breast)

Physician

Join to view full profile

Dr. Mittendorf is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Mittendorf's full profile

Already have an account?

Office
450 Brookline Avenue
Boston, MA 02215
Phone+1 617-582-9277

Education & Training

University of Texas M D Anderson Cancer CenterFellowship, Complex General Surgical Oncology, 2005 - 2008
Case Western Reserve University School of MedicineClass of 1996

Certifications & Licensure

MA State Medical License 2017 - 2025
TX State Medical License 2005 - 2019
OH State Medical License 1997 - 2008
American Board of Surgery Surgery

Clinical Trials

Atezolizumab + Sacituzumab Govitecan to Prevent Recurrence in TNBC (ASPRIA) Start of enrollment: 2020 Jul 02
Active, not recruiting
Phase 2

Publications & Presentations

PubMed

571 citations
Breast Cancer—Major changes in the American Joint Committee on Cancer eighth edition cancer staging manual
Armando E. Giuliano, James L. Connolly, Stephen B. Edge, Elizabeth A. Mittendorf, Hope S. Rugo
CA. 2017-07-08
99 citations
Integrin αvβ6–TGFβ–SOX4 Pathway Drives Immune Evasion in Triple-Negative Breast Cancer
Archis Bagati, Sushil Kumar, Peng Jiang, Jason Pyrdol, Angela E. Zou
Cancer Cell. 2021-01-11
4 citations
Tumor Immune Microenvironment Changes by Multiplex Immunofluorescence Staining in a Pilot Study of Neoadjuvant Talazoparib for Early-Stage Breast Cancer Patients with ...
Tapsi Kumar, Evie Hobbs, Fei Yang, Jeffrey T Chang, Alejandro Contreras
Clinical Cancer Research. 2022-09-01

Press Mentions

Researchers Analyse the Efficacy of Immunotherapy Combined with Chemotherapy in the Treatment of Early Breast CancerSeptember 30th, 2024
Benefits of Neoadjuvant Immunotherapy in Breast Cancer Extend Beyond TNBCAugust 29th, 2024
Lidocaine Presurgery May Improve Survival in Early Breast CancerApril 14th, 2023
Join now to see all